Homecoming’s Practitioner Toolkit is Boosting the Success of Integrative Therapy and Coaching
Homecoming’s Digital Companion Technology is Changing the Way Psychedelic Therapists Work
Homecoming’s Digital Companion Technology is Changing the Way Psychedelic Therapists Work
Deciding to purchase CBD and magic mushrooms can seem daunting, especially if you’re a first-time buyer.
On this episode, Dennis Walker talks with Aaron Paul Orsini, the co-founder of Autistic Psychedelic Community, author of Autism on Acid, and producer of the recently released, therapy-friendly instrumental music album “Psychedelic Symphonies.”
The proposed bill would legalize the “possession and use of lysergic acid diethylamide (LSD), mescaline, psilocybin, and peyote for persons 21 years of age and older.”
People on psychedelics often report sensations of clairvoyance, telepathy, and ESP. We talk with a researcher who investigates psi phenomena in psychedelics
TRIPP offers in-depth and intimate training courses for new KAP facilitators wishing to integrate ketamine into their psychiatric and psychotherapy practice, as well as holistic experiential retreats for first responders and frontline healthcare clinicians.
In the US, Ketamine is a ‘schedule III’ drug and is legal for medical use when prescribed by a licensed medical professional. Canada has similar medical exemptions for the use of Ketamine.
In the course of the year that I microdosed magic mushrooms, my artistic productivity, creativity improved, so did my athletic performance.
This unique model lowers the barrier of entry to become a professional facilitator, making it accessible to a more diverse population of Oregonians, including but not limited to veterans and BIPOC community members.
In this episode, Dennis Walker sits down with Nick Gay, the Head of Product Development at Ousia Labs, to talk about what extraction is and why it has become a focus of many entrepreneurs in the psychedelic space, as well as discussing the massive gray market that is developing in Colorado.
End of content
End of content
By signing up to the Psychedelic Spotlight newsletter you agree to receive electronic communications from Psychedelic Spotlight that may sometimes include advertisements or sponsored content.